Charles Schwab Investment Management Inc Tg Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,269,513 shares of TGTX stock, worth $39.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,269,513
Previous 1,184,609 7.17%
Holding current value
$39.2 Million
Previous $27.7 Million 37.91%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$21.31 - $35.09 $1.81 Million - $2.98 Million
84,904 Added 7.17%
1,269,513 $38.2 Million
Q3 2024

Nov 12, 2024
BUY
$17.21 - $25.28 $136,630 - $200,697
7,939 Added 0.67%
1,184,609 $27.7 Million
Q2 2024

Aug 12, 2024
BUY
$13.32 - $19.19 $414,265 - $596,828
31,101 Added 2.71%
1,176,670 $20.9 Million
Q1 2024

May 08, 2024
BUY
$13.02 - $21.3 $178,022 - $291,234
13,673 Added 1.21%
1,145,569 $17.4 Million
Q4 2023

Feb 06, 2024
BUY
$6.68 - $18.81 $128,349 - $361,415
19,214 Added 1.73%
1,131,896 $19.3 Million
Q3 2023

Nov 08, 2023
BUY
$8.36 - $26.5 $266,449 - $844,608
31,872 Added 2.95%
1,112,682 $9.3 Million
Q2 2023

Aug 09, 2023
BUY
$15.48 - $35.0 $542,697 - $1.23 Million
35,058 Added 3.35%
1,080,810 $26.8 Million
Q1 2023

May 11, 2023
BUY
$10.23 - $19.34 $280,762 - $530,786
27,445 Added 2.7%
1,045,752 $15.7 Million
Q4 2022

Feb 13, 2023
BUY
$5.01 - $11.83 $137,519 - $324,721
27,449 Added 2.77%
1,018,307 $12 Million
Q3 2022

Nov 14, 2022
BUY
$4.57 - $8.4 $224,780 - $413,162
49,186 Added 5.22%
990,858 $5.87 Million
Q2 2022

Aug 15, 2022
SELL
$3.74 - $10.66 $51,428 - $146,585
-13,751 Reduced 1.44%
941,672 $4 Million
Q1 2022

May 13, 2022
BUY
$7.81 - $20.45 $132,996 - $348,243
17,029 Added 1.81%
955,423 $9.09 Million
Q4 2021

Feb 11, 2022
BUY
$15.2 - $35.51 $363,690 - $849,647
23,927 Added 2.62%
938,394 $17.8 Million
Q3 2021

Nov 16, 2021
BUY
$21.78 - $40.45 $999,375 - $1.86 Million
45,885 Added 5.28%
914,467 $30.4 Million
Q2 2021

Aug 16, 2021
BUY
$32.5 - $48.96 $897,617 - $1.35 Million
27,619 Added 3.28%
868,582 $33.7 Million
Q1 2021

May 17, 2021
BUY
$41.61 - $54.3 $4.73 Million - $6.18 Million
113,794 Added 15.65%
840,963 $40.5 Million
Q4 2020

Feb 16, 2021
BUY
$25.27 - $54.9 $862,111 - $1.87 Million
34,116 Added 4.92%
727,169 $37.8 Million
Q3 2020

Nov 13, 2020
BUY
$18.49 - $27.24 $820,863 - $1.21 Million
44,395 Added 6.84%
693,053 $18.5 Million
Q2 2020

Aug 14, 2020
BUY
$8.9 - $21.84 $860,825 - $2.11 Million
96,722 Added 17.52%
648,658 $12.6 Million
Q1 2020

May 15, 2020
BUY
$7.14 - $15.99 $277,660 - $621,819
38,888 Added 7.58%
551,936 $5.43 Million
Q4 2019

Feb 07, 2020
BUY
$5.1 - $11.2 $231,534 - $508,468
45,399 Added 9.71%
513,048 $5.7 Million
Q3 2019

Nov 08, 2019
BUY
$5.38 - $8.99 $167,942 - $280,631
31,216 Added 7.15%
467,649 $2.63 Million
Q2 2019

Aug 09, 2019
BUY
$6.27 - $8.65 $298,357 - $411,610
47,585 Added 12.24%
436,433 $3.78 Million
Q1 2019

May 14, 2019
BUY
$4.02 - $8.04 $163,348 - $326,697
40,634 Added 11.67%
388,848 $3.13 Million
Q4 2018

Feb 14, 2019
BUY
$3.44 - $5.76 $63,870 - $106,945
18,567 Added 5.63%
348,214 $1.43 Million
Q3 2018

Nov 13, 2018
BUY
$5.15 - $14.0 $81,859 - $222,530
15,895 Added 5.07%
329,647 $1.85 Million
Q2 2018

Aug 08, 2018
BUY
$12.5 - $15.0 $569,725 - $683,670
45,578 Added 17.0%
313,752 $4.13 Million
Q1 2018

May 07, 2018
BUY
$8.7 - $16.8 $10,474 - $20,227
1,204 Added 0.45%
268,174 $3.81 Million
Q4 2017

Jan 17, 2018
BUY
$7.35 - $12.3 $172,614 - $288,865
23,485 Added 9.65%
266,970 $2.19 Million
Q3 2017

Nov 13, 2017
BUY
$10.0 - $12.7 $2.43 Million - $3.09 Million
243,485
243,485 $2.89 Million

Others Institutions Holding TGTX

# of Institutions
371
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.49B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email